Dr. Tariot reports grants from NIA, other from Adamas Pharmaceuticals, personal fees and other from Abbvie, personal fees from AC Immune, personal fees from Acadia, personal fees from Athira, personal fees from Axsome, personal fees from BioXcel, personal fees and other from Cortexyme, personal fees from Eisai, personal fees and other from Genentech, personal fees and other from Merck, personal fees from Novo Nordisk, personal fees from Syneos, personal fees from T3D Therapeutics, personal fees and other from Biogen, other from Eli Lilly, other from Novartis, other from Roche, personal fees from Otsuka and Astex, outside the submitted work; In addition, Dr. Tariot has a patent U.S. Patent # 11/632,747, «Biomarkers of Neurodegenerative Disease» issued.